Vir Biotechnology (VIR) Competitor Comparison
We are evaluating the key criteria listed to compare Vir Biotechnology (VIR) against its competitors in the Biotechnology industry.
Market Capitalization
97 / 368Gross Profits
11 / 278Total Revenue
85 / 300EBITDA
329 / 337Free Cashflow
347 / 352Quick Ratio
76 / 357Earnings per Share
282 / 359Dividend yield
0 / 6Total Cash
12 / 358Performance 3 years
280 / 368Performance 5 years
160 / 368Performance 10 years
149 / 368Linearity 3 years
200 / 368Linearity 5 years
41 / 368Linearity 10 years
44 / 367Total Rank
25 / 368Dividend Rank
305 / 368Valuation Rank
97 / 368Piotroski Rank
59 / 368Muliplier Rank
88 / 368Market Capitalization - VIR ranking 97 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.